MedTrop 2024 is the 59th Congress of the Brazilian Society of Tropical Medicine. With the theme ‘One Health‘, the event will explore the interconnection and interdependence between human, animal, plant, and environmental health.
Pre-Congress Workshop
Dates: 18-20 September 2024
Ahead of MedTrop, DNDi, in partnership with Netherlands Hanseniasis Relief (NHR), will offer an Empowerment Workshop for Leaders Affected by Socially Determined Diseases.
MedTrop
Round table – New therapeutical options for Chagas Disease: Main challenges on registry and production in Latin American countries
Date: Tuesday, 24 September 2024
Time: 10:15 – 12:15
Room: Sala Turquesa 6
Moderators: Maria Jesus Pinazo, Head of Chagas Disease, DNDi and Javier Sancho, Global Chagas Coalition
Challenges in the production and use of benznidazol in Latin America and abroad: what about potential shorter regimens of benznidazol? Silvia Gold, Mundo Sano Foundation and Board Member, DNDi |
Access to Nifurtimox in Latin America: considerations regarding the production and use. Ulrich Madeja, Bayer |
Navigating in challenges: benznidazol use, production, and access in Brazil, with a focus on pediatric treatment Aila Karla Mota Santana, LAFEPE |
The PAHO Strategic Fund and its role in Chagas medicines access in Latin American countries Nora Girón, PAHO |
Registration of potential new chemical compounds for Chagas. What is needed from Pharma to impulse its development Natasha Hochberg, Novartis Caroline Demacq, Novartis |
Technology transfer and production in Latin America of medicines for Chagas disease Eilaine Fonseca Bastos Goulart, Farmanguinhos/Fiocruz |
Access to benznidazol and/or nifurtimox: end-users perspective Nilva Belo, AGPDC – Association of Chagas Disease Patients from Goiania/Go Brazil |
Conference – Uma aliança sul-sul para o desenvolvimento de tratamento para dengue
Date: Wednesday, 25 September 2024
Time: 9:00-9:45
Moderator: Sheila Rodovalho, OPAS-Brasil
Speaker: André Siqueira, Head of Dengue Global Programme, DNDi
ChagasLeish
Workshop – Access to quality diagnosis
Date: Monday, 23 September 2024
Time: 15:40 – 15:55
Room: Sala Turquesa 6
Serological rapid diagnostic tests: Field experience and validation in Colombia Andrea Marchiol, Senior Chagas Access Project Manager, DNDi |
Workshop – Advances in understanding pathogenesis and diagnostic and therapeutic targets: an invisible dimension with great challenges
Date: Monday, 23 September 2024
Time: 16:05 – 16:20
Room: Sala Coral
Treatment targets, diagnosis, and therapeutic response: What’s new? Luiza Cruz, Drug Discovery Coordinator, DNDi |
Round table – Environment and Leishmaniasis
Date: Monday, 23 September 2024
Time: 13:45 to 17:20
Room: Sala Turquesa 4
Session 2: Leishmaniasis and Immunosuppressed, what else do we need to know?
Moderators: Joelle Rode, Senior Leishmaniasis Clinical Project and Medical Manager, DNDi and Marcia Leite de Sousa Gomes, MS- SVSA |
What is the situation with leishmaniasis in immunosuppressed patients in Brazil? Kathiely Martins Dos Santos, MS-SVSA |
Biomarkers associated with the clinical outcome of visceral leishmaniasis in the context of co-infection with HIV Joanna Reis Santos de Oliveira, Instituto Oswaldo Cruz e Instituto Federal do Rio de Janeiro |
Is combined treatment a possible practice? Gláucia Fernandes Cota, Head of Visceral Leishmaniasis Clinical Programme, DNDi |
Asymptomatic Leishmania infection in people living with HIV/AIDS. How urgent is that? Zulma Maria de Medeiros, Fiocruz |
Round table – Environment and leishmaniasis. Is it still a challenge?
Date: Tuesday, 24 September 2024
Time: 14:30 – 14:50
Room: Sala Turquesa 3
Accuracy of rapid serological tests for diagnosing human visceral leishmaniasis Gláucia Fernandes Cota, Head of Visceral Leishmaniasis Clinical Programme, DNDi |
Workshop – Understanding and dealing with the complexities of clinical management
Date: Wednesday, 25 September 2024
Time: 15:45 – 16:00
Room: Sala Turquesa 6
Challenges and approaches to healthcare for indigenous communities (Wiwa and Arhuaco) in Colombia Rafael Herazo, Chagas Medical Focal Point, DNDi |